ABI
Adamant Biomedical Investments Portfolio holdings
AUM
$418M
This Quarter Return
+5.56%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$401M
AUM Growth
–
Cap. Flow
+$401M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
34.69%
Holding
96
New
96
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$20.9M |
| 2 |
CELG
Celgene Corp
CELG
|
$19.6M |
| 3 |
Biogen
BIIB
|
$18.2M |
| 4 |
Amgen
AMGN
|
$14M |
| 5 |
AGN
Allergan plc
AGN
|
$12.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 86.61% |
| 2 | Financials | 1.21% |
| 3 | Industrials | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $20.9M | 5.22% |
+196,390
| New | +$20.9M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $19.6M | 4.89% |
+206,720
| New | +$19.6M |
|
|
3
Biogen
BIIB
$19.4B
| $18.2M | 4.54% |
+55,020
| New | +$18.2M |
|
|
4
Amgen
AMGN
$155B
| $14M | 3.51% |
+100,000
| New | +$14M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $12.6M | 3.14% |
+52,110
| New | +$12.6M |
|
|
SLXP
6
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $12.2M | 3.05% |
+78,210
| New | +$12.2M |
|
7
UnitedHealth
UNH
$281B
| $11M | 2.76% |
+128,000
| New | +$11M |
|
8
Viatris
VTRS
$12.3B
| $10.5M | 2.61% |
+230,000
| New | +$10.5M |
|
|
CYTO
9
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $10M | 2.5% |
+2,169,625
| New | +$10M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.95M | 2.48% |
+60,000
| New | +$9.95M |
|
11
Medtronic
MDT
$119B
| $9.29M | 2.32% |
+150,000
| New | +$9.29M |
|
12
Abbott
ABT
$231B
| $8.32M | 2.08% |
+200,000
| New | +$8.32M |
|
13
Vertex Pharmaceuticals
VRTX
$100B
| $8.2M | 2.05% |
+73,000
| New | +$8.2M |
|
14
McKesson
MCK
$85.4B
| $7.98M | 1.99% |
+41,000
| New | +$7.98M |
|
15
Cardinal Health
CAH
$35.5B
| $7.87M | 1.96% |
+105,000
| New | +$7.87M |
|
|
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $7.21M | 1.8% |
+80,000
| New | +$7.21M |
|
17
Illumina
ILMN
$15.8B
| $7.05M | 1.76% |
+43,000
| New | +$7.05M |
|
18
Centene
CNC
$14.3B
| $6.49M | 1.62% |
+78,460
| New | +$6.49M |
|
19
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.49M | 1.62% |
+18,000
| New | +$6.49M |
|
20
Teva Pharmaceuticals
TEVA
$21.1B
| $6.45M | 1.61% |
+120,000
| New | +$6.45M |
|
|
AGN
21
DELISTED
ALLERGAN INC
AGN
| $6.24M | 1.56% |
+35,000
| New | +$6.24M |
|
22
Molina Healthcare
MOH
$9.8B
| $5.54M | 1.38% |
+131,050
| New | +$5.54M |
|
23
Ionis Pharmaceuticals
IONS
$6.8B
| $5.44M | 1.36% |
+140,000
| New | +$5.44M |
|
|
CTRX
24
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $5.25M | 1.31% |
+136,740
| New | +$5.25M |
|
25
ProShares Ultra NASDAQ Biotechnology
BIB
$53.6M
| $5.2M | 1.3% |
+50,000
| New | +$5.2M |
|